Clinical Trial Update: A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a higher-dose aflibercept eye injection for macular edema due to retinal vein occlusion; results from the completed study have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema Secondary to Retinal Vein Occlusion

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Macular Edema Secondary to Retinal Vein Occlusion | Phase 3 | Status: COMPLETED | Results posted: 2025-12-18